CSGCX
Price
$44.92
Change
+$0.17 (+0.38%)
Updated
Jul 25 closing price
Net Assets
1.42B
RLEFX
Price
$37.17
Change
+$0.07 (+0.19%)
Updated
Jul 25 closing price
Net Assets
254.37B
Interact to see
Advertisement

CSGCX vs RLEFX

Header iconCSGCX vs RLEFX Comparison
Open Charts CSGCX vs RLEFXBanner chart's image
Calvert Balanced C
Price$44.92
Change+$0.17 (+0.38%)
VolumeN/A
Net Assets1.42B
American Funds American Balanced R5E
Price$37.17
Change+$0.07 (+0.19%)
VolumeN/A
Net Assets254.37B
CSGCX vs RLEFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CSGCX vs. RLEFX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSGCX is a Buy and RLEFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 254B vs. CSGCX (1.42B). RLEFX pays higher dividends than CSGCX: RLEFX (2.01) vs CSGCX (0.66). CSGCX was incepted earlier than RLEFX: CSGCX (31 years) vs RLEFX (10 years). CSGCX (1.66) is less costly to investors than RLEFX (0.39). CSGCX is a more actively managed with annual turnover of: 153.00 vs. RLEFX (44.00). RLEFX has a lower initial minimum investment than CSGCX: RLEFX (250) vs CSGCX (1000). RLEFX annual gain was more profitable for investors over the last year : 10.46 vs. CSGCX (8.80). RLEFX return over 5 years is better than : 40.77 vs. CSGCX (33.39).
CSGCXRLEFXCSGCX / RLEFX
Total Expense Ratio1.660.39426%
Annual Report Gross Expense Ratio1.660.39426%
Fund Existence31 years10 years-
Gain YTD5.9609.13365%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.42B254B1%
Annual Yield % from dividends0.662.0133%
Returns for 1 year8.8010.4684%
Returns for 3 years34.9935.4299%
Returns for 5 years33.3940.7782%
Returns for 10 years45.00N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SVRA2.580.03
+1.18%
Savara
WEX175.621.52
+0.87%
WEX
CGON26.10-0.04
-0.15%
CG Oncology
LFVN13.71-0.27
-1.93%
Lifevantage Corp
ISPC1.07-0.03
-2.79%
iSpecimen Inc